We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Aeterna Zentaris Inc | NASDAQ:AEZS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.0038 | -0.19% | 1.9562 | 1.83 | 2.03 | 1.965 | 1.95 | 1.95 | 5,110 | 01:00:00 |
From Apr 2019 to Apr 2024
QUÉBEC CITY, Sept. 3, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chief Financial Officer, Dennis Turpin, will be presenting a corporate overview at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015, at 10:25 am (Eastern), in the Library Room (2nd floor) of the St. Regis Hotel in New York City.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.
Copyright 2015 PR Newswire
1 Year Aeterna Zentaris Chart |
1 Month Aeterna Zentaris Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
